IN8bio, Inc. (INAB) Misses Q2 EPS by 118c
Tweet
Share
E-mailGet Alerts INAB Hot Sheet
Join SI Premium – FREE
IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($1.24), $1.18 worse than the analyst estimate of ($0.06).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- Citi Upgrades Shenzhen T&S Communication (300570:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
